Tocilizumab Plus a Short Prednisone Taper for GCA

NCT03726749 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Giant Cell Arteritis

Interventions

DRUG: Tocilizumab
DRUG: Prednisone

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]